Product Code: BMIRE00031945
The North America pediatric masks market was valued at approximately $304.26 million in 2023 and is projected to grow to around $447.54 million by 2031, reflecting a compound annual growth rate (CAGR) of 4.9% during the forecast period.
Increasing Incidence of Respiratory Disorders
The rise in respiratory diseases among children is a significant factor driving the demand for pediatric masks in North America. Children are particularly vulnerable to respiratory conditions due to environmental factors. Common ailments include asthma, influenza, pneumonia, bronchitis, and chronic obstructive airway diseases. Pneumonia, in particular, is a leading cause of mortality among children, with UNICEF reporting that over 700,000 children die from pneumonia each year worldwide. In the United States, approximately 4.6 million children were diagnosed with asthma in 2021, leading to around 500,000 hospitalizations annually due to this condition, according to the American College of Allergy, Asthma & Immunology.
The increasing number of healthcare facilities, including hospitals, intensive care units (ICUs), clinics, and ambulatory surgical centers, is also contributing to the growth of the pediatric masks market. The American Hospital Association noted a rise in the number of hospitals in the U.S., from 6,090 in 2021 to 6,120 in 2024. Additionally, various initiatives by government and healthcare organizations aim to raise awareness about asthma and respiratory health. For example, the National Asthma Control Program (NACP) by the CDC focuses on asthma surveillance and research to mitigate the disease's impact.
Overview of the North America Pediatric Masks Market
In North America, the United States dominates the pediatric masks market, driven by the high prevalence of asthma, pneumonia, and sleep apnea among children. The demand for innovative pediatric masks that enhance treatment quality is also on the rise. The CDC reported that approximately 4.6 million children in the U.S. had asthma in 2021. Furthermore, the March of Dimes Organization indicated that there were 380,548 preterm births in the U.S. in 2022, accounting for 10.4% of live births. Pediatric masks are essential for assisting preterm infants with their breathing needs, further boosting market demand.
Leading companies in the U.S. pediatric masks market, such as SunMed, ResMed, and Fisher & Paykel, are actively pursuing strategic initiatives to align their operations with market needs. For instance, Dynarex Corporation introduced a new line of portable respiratory therapy products called Dynarex Resp-O2 in April 2024.
Market Segmentation Analysis
The North America pediatric masks market is segmented based on product type, modality, end user, and country:
- Product Type: The market is divided into oxygen masks, nasal cannulas, sleep apnea masks, and others. In 2023, the oxygen mask segment held the largest market share.
- Modality: The market is categorized into disposable and reusable masks, with the disposable segment accounting for a larger share in 2023.
- End Users: The market is segmented into hospitals, specialty clinics, ambulatory surgical centers, diagnostic centers, and others, with hospitals holding the largest share in 2023.
- Country: The market is divided into the U.S., Canada, and Mexico, with the U.S. leading in market share in 2023.
Key Players in the Market
Prominent companies operating in the North America pediatric masks market include Ambu AS, Armstrong Medical Ltd, Besmed Health Business Corp, BLS Systems Limited, Circadiance, Dragerwerk AG & Co KGaA, Dynarex Corp, Fisher & Paykel Healthcare Corp Ltd, Flexicare (Group) Limited, Intersurgical Ltd, Koninklijke Philips NV, ResMed Inc, Sleepnet Corporation, and SunMed Group Holdings LLC (AirLife). These companies are pivotal in shaping the market through innovation and strategic initiatives.
Table Of Contents
1. Introduction
- 1.1 Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Pediatric Masks Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
5. North America Pediatric Masks Market - Key Market Dynamics
- 5.1 North America Pediatric Masks Market - Key Market Dynamics
- 5.2 Market Drivers
- 5.2.1 Increasing Prevalence of Respiratory Disorders
- 5.2.2 Increasing Training Programs for Healthcare Providers
- 5.3 Market Restraints
- 5.3.1 Lack of Reimbursement Policies in Emerging Economies
- 5.4 Market Opportunities
- 5.4.1 Growing Demand for Single-Use Pediatric Masks
- 5.5 Future Trends
- 5.5.1 Increasing Research and Development Activities and Growing Investments in Healthcare
- 5.6 Impact of Drivers and Restraints:
6. North America Pediatric Masks Market - Analysis
- 6.1 North America Pediatric Masks Market Revenue (US$ Million), 2021-2031
- 6.2 North America Pediatric Masks Market Forecast Analysis
7. North America Pediatric Masks Market Analysis - by Product Type
- 7.1 Oxygen Mask
- 7.1.1 Overview
- 7.1.2 Oxygen Mask: North America Pediatric Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 7.2 Nasal Cannula
- 7.2.1 Overview
- 7.2.2 Nasal Cannula: North America Pediatric Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 7.3 Sleep Apnea Mask
- 7.3.1 Overview
- 7.3.2 Sleep Apnea Mask: North America Pediatric Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 7.4 Others
- 7.4.1 Overview
- 7.4.2 Others: North America Pediatric Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
8. North America Pediatric Masks Market Analysis - by Modality
- 8.1 Disposable
- 8.1.1 Overview
- 8.1.2 Disposable: North America Pediatric Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 8.2 Reusable
- 8.2.1 Overview
- 8.2.2 Reusable: North America Pediatric Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
9. North America Pediatric Masks Market Analysis - by End User
- 9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: North America Pediatric Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 9.2 Specialty Clinics
- 9.2.1 Overview
- 9.2.2 Specialty Clinics: North America Pediatric Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 9.3 Ambulatory Surgical Centers
- 9.3.1 Overview
- 9.3.2 Ambulatory Surgical Centers: North America Pediatric Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 9.4 Diagnostic Centers
- 9.4.1 Overview
- 9.4.2 Diagnostic Centers: North America Pediatric Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: North America Pediatric Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
10. North America Pediatric Masks Market - Country Analysis
- 10.1 North America
- 10.1.1 North America Pediatric Masks Market - Revenue and Forecast Analysis - by Country
- 10.1.1.1 North America Pediatric Masks Market - Revenue and Forecast Analysis - by Country
- 10.1.1.2 United States: North America Pediatric Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.1.1.2.1 United States: North America Pediatric Masks Market Share - by Product Type
- 10.1.1.2.2 United States: North America Pediatric Masks Market Share - by Modality
- 10.1.1.2.3 United States: North America Pediatric Masks Market Share - by End User
- 10.1.1.3 Canada: North America Pediatric Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.1.1.3.1 Canada: North America Pediatric Masks Market Share - by Product Type
- 10.1.1.3.2 Canada: North America Pediatric Masks Market Share - by Modality
- 10.1.1.3.3 Canada: North America Pediatric Masks Market Share - by End User
- 10.1.1.4 Mexico: North America Pediatric Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.1.1.4.1 Mexico: North America Pediatric Masks Market Share - by Product Type
- 10.1.1.4.2 Mexico: North America Pediatric Masks Market Share - by Modality
- 10.1.1.4.3 Mexico: North America Pediatric Masks Market Share - by End User
11. Company Profiles
- 11.1 Koninklijke Philips NV
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
- 11.2 ResMed Inc
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
- 11.3 BLS Systems Limited
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
- 11.4 Besmed Health Business Corp
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
- 11.5 Flexicare (Group) Limited
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
- 11.6 Sleepnet Corporation.
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
- 11.7 Circadiance.
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
- 11.8 Dynarex Corp
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
- 11.9 Intersurgical Ltd
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
- 11.10 Armstrong Medical Ltd
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 1Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments
- 11.11 Ambu AS
- 11.11.1 Key Facts
- 11.11.2 Business Description
- 11.11.3 Products and Services
- 11.11.4 Financial Overview
- 11.11.5 SWOT Analysis
- 11.11.6 Key Developments
- 11.12 SunMed Group Holdings LLC ( AirLife)
- 11.12.1 Key Facts
- 11.12.2 Business Description
- 11.12.3 Products and Services
- 11.12.4 Financial Overview
- 11.12.5 SWOT Analysis
- 11.12.6 Key Developments
- 11.13 Dragerwerk AG & Co KGaA
- 11.13.1 Key Facts
- 11.13.2 Business Description
- 11.13.3 Products and Services
- 11.13.4 Financial Overview
- 11.13.5 SWOT Analysis
- 11.13.6 Key Developments
- 11.14 Fisher & Paykel Healthcare Corp Ltd
- 11.14.1 Key Facts
- 11.14.2 Business Description
- 11.14.3 Products and Services
- 11.14.4 Financial Overview
- 11.14.5 SWOT Analysis
- 11.14.6 Key Developments
12. Appendix
- 12.1 About The Insight Partners
- 12.2 Glossary of Terms